APH PPT.pdf
•
0 likes•55 views
Maternal vaccination is an effective strategy to protect both mothers and infants from life-threatening illnesses. Vaccines administered during pregnancy allow antibodies to cross the placenta, protecting both the developing fetus and newborn. Immunizing women between 27 and 36 weeks of gestation maximizes the transfer of protective antibodies, as the third trimester provides the greatest opportunity for the fetus to receive antibodies before birth. Maternal vaccination helps reduce the risk of infection transmission from mother to infant.
APH PPT.pdf
- 2. APH,PPH AND MATERNAL VACCINATION ï‚´ ï‚´ Nipa Adhikary BSN(DU),MSS(DU),MPH In-course (NIPSOM)
- 61. Maternal Immunization/Vaccination Maternal immunization is a promising strategy for protecting mothers, the developing fetus, and young infants during a particularly vulnerable time in their lives – especially in low- and middle-income countries where morbidity and mortality among women and their children is high. During pregnancy, vaccines allow antibodies from the mother to cross into the placenta, protecting moms and their babies from life-threatening illnesses.
- 66. Importance of immunization to pregnant woman ï‚´Immunizing during pregnancy provides the opportunity to protect both the pregnant woman and her infant by transplacental transfer of vaccine- induced antibody during the third trimester of pregnancy with the additional benefit of reduced risk of transmission of infection from mother to infant.
- 67. The recommended timing for maternal Tdap vaccination is between 27 weeks and 36 weeks of gestation. To maximize the maternal antibody response and passive antibody transfer and levels in the newborn, vaccination as early as possible in the 27–36-weeks-of-gestation window is recommended.